BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35199829)

  • 1. Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish.
    Ai X; Ye Z; Xiao C; Zhong J; Lancman JJ; Chen X; Pan X; Yang Y; Zhou L; Wang X; Shi H; Zhang D; Yao Y; Cao D; Zhao C
    Dis Model Mech; 2022 Apr; 15(4):. PubMed ID: 35199829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
    Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
    BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
    Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
    Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time evaluation of glioblastoma growth in patient-specific zebrafish xenografts.
    Almstedt E; Rosén E; Gloger M; Stockgard R; Hekmati N; Koltowska K; Krona C; Nelander S
    Neuro Oncol; 2022 May; 24(5):726-738. PubMed ID: 34919147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma research on zebrafish xenograft models: a systematic review.
    Pliakopanou A; Antonopoulos I; Darzenta N; Serifi I; Simos YV; Katsenos AP; Bellos S; Alexiou GA; Kyritsis AP; Leonardos I; Vezyraki P; Peschos D; Tsamis KI
    Clin Transl Oncol; 2024 Feb; 26(2):311-325. PubMed ID: 37400666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An orthotopic glioblastoma animal model suitable for high-throughput screenings.
    Pudelko L; Edwards S; Balan M; Nyqvist D; Al-Saadi J; Dittmer J; Almlöf I; Helleday T; Bräutigam L
    Neuro Oncol; 2018 Oct; 20(11):1475-1484. PubMed ID: 29750281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
    Wang W; Li Y; Lin K; Wang X; Tu Y; Zhuo Z
    Animal Model Exp Med; 2023 Oct; 6(5):381-398. PubMed ID: 37679891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting GBM with an Oncolytic Picornavirus SVV-001 alone and in combination with fractionated Radiation in a Novel Panel of Orthotopic PDX models.
    Zhang H; Du Y; Qi L; Xiao S; Braun FK; Kogiso M; Huang Y; Huang F; Abdallah A; Suarez M; Karthick S; Ahmed NM; Salsman VS; Baxter PA; Su JM; Brat DJ; Hellenbeck PL; Teo WY; Patel AJ; Li XN
    J Transl Med; 2023 Jul; 21(1):444. PubMed ID: 37415222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speeding up Glioblastoma Cancer Research: Highlighting the Zebrafish Xenograft Model.
    Alberti G; Amico MD; Caruso Bavisotto C; Rappa F; Marino Gammazza A; Bucchieri F; Cappello F; Scalia F; Szychlinska MA
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Orthotopic Patient-Derived Xenograft Models of Pediatric Intracranial Tumors.
    Upton DH; Ziegler DS; Tsoli M
    Methods Mol Biol; 2024; 2806():75-90. PubMed ID: 38676797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma.
    Finotto L; Cole B; Giese W; Baumann E; Claeys A; Vanmechelen M; Decraene B; Derweduwe M; Dubroja Lakic N; Shankar G; Nagathihalli Kantharaju M; Albrecht JP; Geudens I; Stanchi F; Ligon KL; Boeckx B; Lambrechts D; Harrington K; Van Den Bosch L; De Vleeschouwer S; De Smet F; Gerhardt H
    EMBO Mol Med; 2023 Nov; 15(11):e18144. PubMed ID: 37791581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion.
    Gamble JT; Reed-Harris Y; Barton CL; La Du J; Tanguay R; Greenwood JA
    Biochem Biophys Res Commun; 2018 Dec; 506(4):833-839. PubMed ID: 30389143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening.
    Stackhouse CT; Rowland JR; Shevin RS; Singh R; Gillespie GY; Willey CD
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
    Xu Z; Kader M; Sen R; Placantonakis DG
    Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.
    Kerstetter-Fogle AE; Harris PLR; Brady-Kalnay SM; Sloan AE
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain.
    Peglion F; Coumailleau F; Etienne-Manneville S
    J Vis Exp; 2022 Jul; (185):. PubMed ID: 35969108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.
    Crommentuijn MH; Maguire CA; Niers JM; Vandertop WP; Badr CE; Würdinger T; Tannous BA
    Mol Oncol; 2016 Apr; 10(4):625-34. PubMed ID: 26708508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Clinical Concordance of Drug Resistance in Patient-derived Orthotopic Xenograft (PDOX) Mouse Models: First Step to Validated Precise Individualized Cancer Chemotherapy.
    Higuchi T; Yamamoto N; Hayashi K; Miwa S; Igarashi K; Tsuchiya H; Hoffman RM
    Anticancer Res; 2023 Oct; 43(10):4277-4284. PubMed ID: 37772554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood-Brain Barrier.
    Kim M; Ma DJ; Calligaris D; Zhang S; Feathers RW; Vaubel RA; Meaux I; Mladek AC; Parrish KE; Jin F; Barriere C; Debussche L; Watters J; Tian S; Decker PA; Eckel-Passow JE; Kitange GJ; Johnson AJ; Parney IF; Anastasiadis PZ; Agar NYR; Elmquist WF; Sarkaria JN
    Mol Cancer Ther; 2018 Sep; 17(9):1893-1901. PubMed ID: 29970480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.